(MedPage Today) — ORLANDO — New results from the randomized CAHtalyst trials shed light on the benefits of crinecerfont (Crenessity) for adult and pediatric patients with congenital adrenal hyperplasia (CAH), a rare genetic condition where…
Source link : https://www.medpagetoday.com/meetingcoverage/aace/115609
Author :
Publish date : 2025-05-15 21:42:00
Copyright for syndicated content belongs to the linked Source.
